Badawi Mohamed Abouseif, Alkhoori Amal, Alkaabi Anoud Saeed, Khalaf Mona, Mohamed Hayam, Almarzooqi Saeeda
Department of Pediatrics-Neonatology Division, Al Qassimi Women's and Children's Hospital, Sharjah, UAE.
Department of Pathology, College of Medicine and Health Sciences, United Arab Emirates University, Abu Dhabi, UAE.
Pediatr Dev Pathol. 2025 Jan-Feb;28(1):74-77. doi: 10.1177/10935266241284949. Epub 2024 Oct 23.
Hereditary multiple intestinal atresia (HMIA) with mutation is caused by homozygous or compound heterozygous gene mutation. It is characterized by multiple small and large intestinal atresias and/or stenoses. mutation is described in some patients with inflammatory bowel disease and mild-severe forms of severe combined immunodeficiency without intestinal atresia or stenosis. We present 2 cases of intestinal atresia and documented mutation with a novel variant. Both cases had different clinical and pathological manifestations. The first case is a male infant born at 35 weeks of gestation with failure to pass meconium. Intestinal biopsy reveals apoptotic enteropathy with villous atrophy and increased mucosal eosinophils. The second case is referred at birth for antenatally detected umbilical hernia, polyhydramnios and possible upper intestinal obstruction. The resected specimen reveals ileal atresia with partial villous atrophy, decreased number of lamina propria inflammatory cells and absence of plasma cells. In conclusion, these cases reflect an emerging pathogenic variant with different histological manifestations and leads to characterization as immune dysregulation disorder. There is a need to differentiate mutation associated ones from cases labeled as very early onset IBD and rule out other hereditary immunodeficiencies.
具有突变的遗传性多发性肠闭锁(HMIA)由纯合或复合杂合基因突变引起。其特征为多个小肠和大肠闭锁和/或狭窄。在一些炎症性肠病患者以及无肠闭锁或狭窄的轻至重度严重联合免疫缺陷患者中描述了该突变。我们报告2例肠闭锁病例,并记录了一种新变异的该突变。两例均有不同的临床和病理表现。第一例是一名孕35周出生的男婴,出生后未排胎便。肠道活检显示凋亡性肠病伴绒毛萎缩和黏膜嗜酸性粒细胞增多。第二例在出生时因产前检测到脐疝、羊水过多和可能的上消化道梗阻而转诊。切除标本显示回肠闭锁伴部分绒毛萎缩、固有层炎症细胞数量减少且无浆细胞。总之,这些病例反映了一种新出现的具有不同组织学表现的致病变异,并导致其被归类为免疫失调疾病。有必要将与该突变相关的病例与标记为极早发型炎症性肠病的病例区分开来,并排除其他遗传性免疫缺陷。